植物组织培养市场－全球产业规模、份额、趋势、机会、预测：按成分、植物类型、应用、地区和竞争格局划分，2021-2031年

全球植物组织培养市场预计将从 2025 年的 4.1162 亿美元成长到 2031 年的 6.0878 亿美元，复合年增长率为 6.74%。

这项技术是在无菌条件下，在营养培养基上培养植物细胞，从而获得基因相同的克隆体。它是生产高品质、无病原体且不受季节限制的种植材料的关键步骤。对高产作物和优质观赏植物日益增长的需求正在推动该行业的发展，因为它有助于维持商业农业的繁荣。正如国际园艺种植者协会所指出的，预计到2024年，全球观赏园艺产业规模将达到700亿美元，凸显了对繁殖材料的巨大需求，而这正是组织培养市场的基础。

进一步扩张的驱动力在于对新品种植物的快速繁殖的需求，而这些新品种无法透过传统的繁殖方法实现，尤其是在林业和园艺领域。儘管实验室的自动化程度正在逐步提高，但与精细的手动操作相关的、需要专门基础设施的高昂营运成本仍然是市场成长的主要障碍。因此，成长的主要障碍是熟练技术人员的严重短缺，这推高了生产成本，并限制了在价格敏感型市场中的扩充性。

市场驱动因素

政府加强对农业生物技术研究的投入和支持，正从根本上改变全球植物组织培养市场，为技术创新和基础建设提供必要的资金。公共部门的投资日益集中于基因研究和合成生物学领域，这些领域高度依赖组织培养流程进行繁殖和再生。这些资金支持使实验室能够升级无菌设施并实施先进的自动化技术，从而直接降低该行业的高昂营运成本。例如，英国研究与发展组织（UKRI）于2025年11月宣布，英国政府已将其在生物技术领域的投资增加近三倍，达到6.44亿英镑，以促进成长和创新。这些措施将降低商业机构的财务风险，并为大规模微繁殖技术的发展创造有利环境。

同时，对高产、无病害种苗日益增长的需求成为关键的商业性驱动力，领先的农产品企业正致力于利用组织培养技术大规模克隆优良基因。由于病原体威胁传统的作物繁殖方式，组织培养提供的无菌环境确保了健康、洁净的初始种苗供应，这对粮食安全至关重要。各公司正投入大量资金研发这些抗病品种。根据拜耳公司2025年3月发布的《2024年度报告》，该公司作物科学部门已在研发方面投资26亿欧元，凸显了农业产业对创新的坚定承诺。这种高品质种苗的需求支撑着整个供应链，而先正达集团2025年第一季73亿美元的销售额也印证了基于组织培养技术的先进农产品在全球范围内的巨大规模。

市场挑战

熟练技术人员的严重短缺是全球植物组织培养市场成长的主要障碍。由于组织培养过程仍然是劳力密集的，需要精细的手工操作和专业的技能来维持扩充性和遗传一致性，因此技术人员短缺直接增加了营运成本并限制了规模化生产。与可以轻鬆过渡到全面自动化的行业不同，植物组织培养在精确的切取和继代培养作业方面仍然高度依赖人工经验。因此，如果实验室无法聘用足够训练有素的技术人员，就会出现生产瓶颈，可能无法满足全球对高品质种植材料日益增长的需求。

劳动力短缺正导致巨大的经济损失和市场机会的丧失。高职缺率迫使生产者限制产量，有效地抑制了依赖植物品种快速繁殖的园艺景观产业的扩张。例如，加拿大园艺景观协会在2024年报告称，由于劳动力短缺，园艺景观产业将遭受5亿美元的销售损失。这些数据凸显了劳动力不足如何直接导致利润下降，并阻碍市场的整体成长。

市场趋势

大麻和工业大麻专用组织培养通讯协定的快速发展正在重塑市场格局。这主要源自于对无病害、基因均一克隆植株的需求。微繁殖技术能够大规模生产具有精确复製的品种特征的植株，满足商业种植的需求，其均一性远超传统种子繁殖。该领域正经历爆炸性增长，而先进的无菌操作流程对于解决优质种苗供不应求至关重要。根据美国农业部2025年4月发布的《国家大麻报告》，2024年美国大麻总产量将达4.45亿美元，比前一年增加40%。这直接推动了工业规模微繁殖技术的普及应用。

同时，组织培养技术正发展成为基于CRISPR基因编辑工作流程中的基础再生平台。各实验室正在引进精准的基因组编辑工具，以培育具有改良性状的独特品种，这些品种需要利用体外技术从单细胞再生为单株植物。领先的农业生物技术公司正大力投资于此应用领域，旨在为下一代作物获取智慧财产权。正如Corteva AgriScience在2025年4月发布的《2024年影响力报告》中所强调的，该公司正在加大对基因编辑平台的投资，每天投入约400万美元用于研发和创新，凸显了支撑这些先进再生技术的雄厚资金实力。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球植物组织培养市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依组成部分（培养基、试剂、设备/容器）
  • 植物种类（一年生植物、二年生植物、多年生植物）
  • 按应用领域（农业、林业/植物园、园艺/装饰、调查、其他）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美植物组织培养市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国别分析
  • 我们
  • 加拿大
  • 墨西哥

第七章：欧洲植物组织培养市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国别分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区植物组织培养市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国别分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲植物组织培养市场展望

• 市场规模及预测
• 市占率及预测
• 中东与非洲：国别分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲植物组织培育市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国别分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 促进因素
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 近期趋势

第十三章 全球植物组织培养市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的议价能力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• HiMedia Laboratories Pvt. Ltd
• 3R Biotech
• Merck KGaA
• Labland Biotech Private Limited
• Melford Laboratories Ltd.
• RUBI LABORATORIES, INC.
• Phytoclone Inc
• PhytoTech Labs, Inc.
• Caisson Labs Inc.
• Thomas Scientific LLC

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Plant Tissue Culture Market is projected to expand from USD 411.62 Million in 2025 to USD 608.78 Million by 2031, registering a CAGR of 6.74%. This technique relies on the sterile in vitro cultivation of plant cells on nutrient media to create genetically identical clones, a critical process for producing high-quality planting materials that are free from pathogens and not bound by seasonal limitations. The industry is driven by increasing requirements for high-yield crops and premium ornamental plants to sustain commercial agriculture. As noted by the International Association of Horticultural Producers, the global ornamental horticulture sector was valued at $70 billion in 2024, emphasizing the substantial demand for propagation materials that underpins the tissue culture market.

Further expansion is fueled by the need for rapid multiplication of novel plant varieties, especially within forestry and floriculture, which conventional propagation cannot achieve. Although laboratories are progressively integrating automation, the market faces a substantial hurdle regarding high operational expenses due to the delicate, manual nature of the process requiring specialized infrastructure. Consequently, a primary challenge hindering growth is the severe scarcity of skilled technical staff, which increases production costs and limits scalability in price-sensitive markets.

Market Driver

Escalating government funding and support for agricultural biotechnology research is fundamentally transforming the Global Plant Tissue Culture Market by supplying essential capital for technical innovation and infrastructure. Public sector investments are increasingly focused on genetic research and engineering biology, fields that depend heavily on tissue culture workflows for propagation and regeneration. This financial support allows laboratories to modernize sterile facilities and implement advanced automation, directly mitigating the sector's high operational expenses. For instance, UK Research and Innovation announced in November 2025 that the UK government had nearly tripled its investment in engineering biology to £644 million to stimulate growth and innovation. Such initiatives decrease financial risks for commercial entities and create an environment favorable for large-scale micropropagation developments.

Simultaneously, the growing necessity for high-yielding and disease-free planting material serves as a crucial commercial catalyst, pushing major agribusinesses toward tissue culture for the mass cloning of superior genetics. With pathogens posing threats to traditional crop propagation, the sterile environment provided by tissue culture guarantees the supply of vigorous, clean starting material necessary for food security. Corporations are allocating vast resources to develop these resilient varieties; according to Bayer's "Annual Report 2024" released in March 2025, its Crop Science division invested €2.6 billion in research and development, highlighting the industry's dedication to agricultural innovation. This demand for premium inputs supports the entire supply chain, as evidenced by Syngenta Group reporting first-quarter sales of $7.3 billion in 2025, demonstrating the immense global scale for advanced agricultural products underpinned by tissue culture.

Market Challenge

The severe shortage of skilled technical personnel represents a critical impediment to the growth of the Global Plant Tissue Culture Market. This deficit directly increases operational costs and constrains scalability because the tissue culture process remains labor-intensive, requiring delicate manual steps and specialized handling to maintain sterility and genetic uniformity. Unlike industries that can easily shift to complete automation, plant tissue culture continues to depend heavily on human expertise for precise excision and sub-culturing tasks. As a result, when laboratories are unable to recruit sufficient trained technicians, they encounter production bottlenecks that hinder their ability to satisfy the rising global demand for high-quality planting materials.

This workforce gap leads to substantial economic losses and missed market opportunities. High vacancy rates compel producers to restrict their output, effectively stalling expansion in a sector that depends on the rapid multiplication of plant varieties. For example, the Canadian Nursery Landscape Association reported in 2024 that the floriculture and nursery landscape industry suffered $500 million in lost sales specifically due to job vacancies. This data highlights how the inability to adequately staff operations results directly in diminished revenue and inhibits the overall trajectory of the market.

Market Trends

The rapid development of specialized tissue culture protocols for cannabis and industrial hemp is reshaping the market, fueled by the essential requirement for disease-free, genetically uniform clones. Micropropagation facilitates the mass production of true-to-type plants necessary for commercial cultivation, offering a level of consistency that traditional seed propagation cannot provide. This segment is undergoing explosive growth, requiring advanced sterile workflows to address the supply shortage of premium planting material. According to the USDA's "National Hemp Report" from April 2025, the total value of U.S. hemp production reached $445 million in 2024, a 40 percent increase from the prior year, which is directly accelerating the adoption of industrial-scale micropropagation.

Concurrently, tissue culture is evolving into a fundamental regeneration platform for CRISPR-based gene editing workflows. Laboratories are incorporating precise genome editing tools to create proprietary plant varieties with improved traits, which must be regenerated from single cells into whole plants using in vitro techniques. This application draws significant capital from major ag-biotech companies seeking to secure intellectual property in next-generation crops. As noted in Corteva Agriscience's "Impact Report 2024" published in April 2025, the company has increased its investment in gene editing platforms and commits nearly $4 million daily to R&D innovation, underscoring the massive financial backing supporting these advanced regeneration technologies.

Key Market Players

• HiMedia Laboratories Pvt. Ltd
• 3R Biotech
• Merck KGaA
• Labland Biotech Private Limited
• Melford Laboratories Ltd.
• RUBI LABORATORIES, INC.
• Phytoclone Inc
• PhytoTech Labs, Inc.
• Caisson Labs Inc.
• Thomas Scientific LLC

Report Scope

In this report, the Global Plant Tissue Culture Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Plant Tissue Culture Market, By Component

• Media
• Reagents
• Equipment & Containers

Plant Tissue Culture Market, By Plant Type

• Annual Plants
• Biennial Plants
• Perennial Plants

Plant Tissue Culture Market, By End Use

• Agriculture
• Forestry and Botanical Garden
• Gardening & Decoration
• Research
• Others

Plant Tissue Culture Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Plant Tissue Culture Market.

Available Customizations:

Global Plant Tissue Culture Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Plant Tissue Culture Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Component (Media, Reagents, Equipment & Containers)
  • 5.2.2. By Plant Type (Annual Plants, Biennial Plants, Perennial Plants)
  • 5.2.3. By End Use (Agriculture, Forestry and Botanical Garden, Gardening & Decoration, Research, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Plant Tissue Culture Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Component
  • 6.2.2. By Plant Type
  • 6.2.3. By End Use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Plant Tissue Culture Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Component
      • 6.3.1.2.2. By Plant Type
      • 6.3.1.2.3. By End Use
  • 6.3.2. Canada Plant Tissue Culture Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Component
      • 6.3.2.2.2. By Plant Type
      • 6.3.2.2.3. By End Use
  • 6.3.3. Mexico Plant Tissue Culture Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Component
      • 6.3.3.2.2. By Plant Type
      • 6.3.3.2.3. By End Use

7. Europe Plant Tissue Culture Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Component
  • 7.2.2. By Plant Type
  • 7.2.3. By End Use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Plant Tissue Culture Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Component
      • 7.3.1.2.2. By Plant Type
      • 7.3.1.2.3. By End Use
  • 7.3.2. France Plant Tissue Culture Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Component
      • 7.3.2.2.2. By Plant Type
      • 7.3.2.2.3. By End Use
  • 7.3.3. United Kingdom Plant Tissue Culture Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Component
      • 7.3.3.2.2. By Plant Type
      • 7.3.3.2.3. By End Use
  • 7.3.4. Italy Plant Tissue Culture Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Component
      • 7.3.4.2.2. By Plant Type
      • 7.3.4.2.3. By End Use
  • 7.3.5. Spain Plant Tissue Culture Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Component
      • 7.3.5.2.2. By Plant Type
      • 7.3.5.2.3. By End Use

8. Asia Pacific Plant Tissue Culture Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Component
  • 8.2.2. By Plant Type
  • 8.2.3. By End Use
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Plant Tissue Culture Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Component
      • 8.3.1.2.2. By Plant Type
      • 8.3.1.2.3. By End Use
  • 8.3.2. India Plant Tissue Culture Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Component
      • 8.3.2.2.2. By Plant Type
      • 8.3.2.2.3. By End Use
  • 8.3.3. Japan Plant Tissue Culture Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Component
      • 8.3.3.2.2. By Plant Type
      • 8.3.3.2.3. By End Use
  • 8.3.4. South Korea Plant Tissue Culture Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Component
      • 8.3.4.2.2. By Plant Type
      • 8.3.4.2.3. By End Use
  • 8.3.5. Australia Plant Tissue Culture Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Component
      • 8.3.5.2.2. By Plant Type
      • 8.3.5.2.3. By End Use

9. Middle East & Africa Plant Tissue Culture Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Component
  • 9.2.2. By Plant Type
  • 9.2.3. By End Use
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Plant Tissue Culture Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Component
      • 9.3.1.2.2. By Plant Type
      • 9.3.1.2.3. By End Use
  • 9.3.2. UAE Plant Tissue Culture Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Component
      • 9.3.2.2.2. By Plant Type
      • 9.3.2.2.3. By End Use
  • 9.3.3. South Africa Plant Tissue Culture Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Component
      • 9.3.3.2.2. By Plant Type
      • 9.3.3.2.3. By End Use

10. South America Plant Tissue Culture Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Component
  • 10.2.2. By Plant Type
  • 10.2.3. By End Use
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Plant Tissue Culture Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Component
      • 10.3.1.2.2. By Plant Type
      • 10.3.1.2.3. By End Use
  • 10.3.2. Colombia Plant Tissue Culture Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Component
      • 10.3.2.2.2. By Plant Type
      • 10.3.2.2.3. By End Use
  • 10.3.3. Argentina Plant Tissue Culture Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Component
      • 10.3.3.2.2. By Plant Type
      • 10.3.3.2.3. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Plant Tissue Culture Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. HiMedia Laboratories Pvt. Ltd
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. 3R Biotech
• 15.3. Merck KGaA
• 15.4. Labland Biotech Private Limited
• 15.5. Melford Laboratories Ltd.
• 15.6. RUBI LABORATORIES, INC.
• 15.7. Phytoclone Inc
• 15.8. PhytoTech Labs, Inc.
• 15.9. Caisson Labs Inc.
• 15.10. Thomas Scientific LLC

16. Strategic Recommendations

17. About Us & Disclaimer